鞘内巴氯芬治疗研究的发表趋势:文献计量学分析
该文献计量学分析检索Scopus数据库(2022年2月),纳入1985至2022年615篇鞘内巴氯芬(ITB)治疗相关文章,分析引用数、发表年份、国家收入类别、期刊影响因子、研究类型等。结果显示平均每篇引用27.47次(95%CI 23.75-31.18),平均影响因子4.54(95%CI 3.84-5.24),76.42%为原始研究,美国发表最多,高收入国家占96.42%。
要点
- 1985至2022年共纳入615篇ITB治疗相关文章,平均每篇被引27.47次(95%CI 23.75-31.18)。
- 原始研究占76.42%,其中干预性研究占8.1%,观察性研究占91.9%。
- 二次研究和病例报告分别占12.68%和10.73%,叙述性综述占二次研究的79.48%。
核心结论
- ITB文章和引用数量上升,表明该领域兴趣增长和知识扩展。
- 低收入和中等收入国家的研究明显稀缺,尤其是ITB可治疗疾病高流行的国家。
- 强调需要更多证据以克服ITB实施的潜在障碍。
- 尽管发表数量增加,大部分证据水平较低(如病例报告和叙述性综述),需要更严谨的研究方法以巩固ITB治疗的证据基础。
研究设计与样本
- 文献计量学分析,检索Elsevier的Scopus数据库(2022年2月),纳入1985至2022年615篇聚焦ITB治疗的文章。
- 提取数据包括引用数、发表年份、作者国家及收入类别、期刊及其5年影响因子、研究类型、需要ITB的疾病和目标人群。
主要发现
- 平均每篇文章引用27.47次(95%CI 23.75-31.18),平均影响因子4.54(95%CI 3.84-5.24)。
- 原始研究占76.42%,其中干预性研究占8.1%,观察性研究占91.9%。
- 被引前10的文章中有一半为干预性研究。
- 二次研究占12.68%,病例报告占10.73%;二次研究中叙述性综述占79.48%,仅1项研究进行了Meta分析。
- 美国是发表最多的国家,高收入国家发表96.42%的文章。
关键数值与推荐
- 平均每篇文章引用27.47次(95%CI 23.75-31.18)。
- 平均影响因子4.54(95%CI 3.84-5.24)。
- 原始研究占76.42%,其中干预性研究占8.1%,观察性研究占91.9%。
- 二次研究占12.68%,病例报告占10.73%;二次研究中叙述性综述占79.48%。
- 高收入国家发表96.42%的文章。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to analyze the trends in publications on intrathecal baclofen (ITB) therapy. METHODS: We searched Elsevier's Scopus database in February 2022 to find articles focused on ITB therapy. Data extracted included citation count, publication year, author's country and income category, journal and its 5-year impact factor, research type, disease requiring ITB, and target population. RESULTS: The analysis covered 615 articles from 1985 to 2022. The average citation count per article was 27.47 (95% confidence interval 23.75-31.18) and the mean impact factor was 4.54 (95% confidence interval 3.84-5.24). The majority (76.42%) were primary research, with 8.1% being interventional and 91.9% observational. Even so, one half of the top ten most cited were interventional. Secondary research and case reports made up 12.68% and 10.73% respectively, with narrative reviews making up most of the secondary research (79.48%). Only 1 study conducted a meta-analysis. The United States was the most prolific country. High-income countries published 96.42% of articles. CONCLUSIONS: The rising number of ITB articles and citations indicates growing interest and expanding knowledge in this field. However, there's a notable scarcity of research from low- and middle-income countries, particularly those with high prevalence of ITB-treatable diseases. The need for more evidence to overcome potential barriers to ITB implementation is emphasized. Despite an increasing number of publications, a large proportion presented low levels of evidence, such as case reports and narrative reviews, highlighting the need for more rigorous research methods to solidify the evidence base for ITB therapy.
引用
- Rech MM, Ramos MB, Piva FE, et al. Publication Trends of Research on Intrathecal Baclofen Therapy: A Bibliometric Analysis of the Literature. World Neurosurg. 2023. PMID: 37567560. doi:10.1016/j.wneu.2023.08.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。